Search results
Author(s):
Tamar S Polonsky
,
Victor Mor-Avi
,
Roberto M Lang
Added:
3 years ago
Cardiac imaging has become fully integrated in the management of patients, with echocardiography being the most widely used modality. Two-dimensional echocardiography (2DE) offers a detailed assessment of ventricular function, valvular pathology, and hemodynamics, but its comprehensiveness is limited by the fact that images represent a single plane, and may thus inadequately represent a heart…
View more
Who should be referred for TAVR?
Author(s):
Colin M Barker
,
Michael J Reardon
Added:
3 years ago
Article
TCT 23: IFR SWEDEHEART
Author(s):
Matthias Gotberg
Added:
4 months ago
Video
Author(s):
Jakub Podolec
,
Lukasz Niewiara
Added:
3 years ago
Atherosclerosis is the primary cause of coronary artery disease morbidity and mortality worldwide.1 Low-density lipoprotein cholesterol (LDL-C)- lowering therapies have already become one of the most important in the prevention of atherosclerosis complications.2 Evolocumab is a human monoclonal antibody that inhibits proprotein convertase subtilisin/kexin type 9 (PCSK9) and thus significantly…
View more
Author(s):
Stacey Neuman
,
Micheal P Howard
,
John D Day
Added:
3 years ago
Implantable cardioverter–defibrillators (ICDs) are being implanted in an ever-increasing number of patients at risk for sudden cardiac death. To ensure the efficacy of the defibrillation system, step-down defibrillation threshold (DFT) testing has traditionally been used to ensure that the ICD can appropriately detect and terminate clinical ventricular fibrillation (VF).
Currently, the most…
View more
Added:
3 years ago
HRT Linked to Heart Attack Reduction in Women Under 60 Years
Hormone replacement therapy (HRT) could reduce heart attacks in women under the age of 60 by up to one-third.
A study, conducted by researchers from Stanford and Cornell universities, analyzed statistical data for over 39,000 women. It uncovered that, for women who began HRT treatment to relieve menopausal symptoms whilst in their 50s,…
View more
Author(s):
Krzysztof Pujdak
,
Jan Kähler
,
Marc Werner
Added:
3 years ago
Significant stenosis of the left main (LM) coronary artery is observed in 7% of coronary angiographies.1 Coronary artery bypass grafting has traditionally been the treatment of choice. In recent years, percutaneous coronary intervention (PCI) has evolved as an alternative, especially for low and intermediate SYNTAX score patients.2 However, during PCI of bifurcation lesions, approximately 50% of…
View more
Author(s):
Naima Maqsood
,
Jeff Healey
Added:
4 months ago
AHA 2023 — Dr Naima Maqsood, CardioNerds ambassador (Temple University Hospital, US) interviews investigator, Dr Jeff Healey (McMaster University, CA) to outline the findings from a phase 4 trial of apixaban to reduce thromboembolism in patients with subclinical atrial fibrillation (AF).ARTESiA (NCT01938248) aims to determine if apixaban in combination with aspirin can reduce the instance of…
View more
Author(s):
Peter H Jones
Added:
3 years ago
High Residual Cardiovascular Risk in Diabetic Patients Treated with Statins
According to the National Cholesterol Education Program Adult Treatment Panel III (NCEP ATPIII), diabetes is a coronary heart disease (CHD) risk equivalent.1 One major factor contributing to the excess risk of cardiovascular disease (CVD) in patients with type 2 diabetes mellitus (T2DM) is atherogenic dyslipidemia,…
View more
Added:
3 years ago
AHA Urges Action by New Congressional Leadership
The American Heart Association (AHA) in November urged the new congressional leadership to increase funding for cardiovascular disease research in order to help prevent a healthcare crisis emerging with the aging of the baby boomers.
With heart diseases and stroke affecting over 70 million adults in the US, rising levels of diabetes and obesity…
View more